Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Clinical and radiological outcomes of 5-year drug-free remission-steered treatment in patients with early arthritis: IMPROVED study.

Akdemir G, Heimans L, Bergstra SA, Goekoop RJ, van Oosterhout M, van Groenendael JHLM, Peeters AJ, Steup-Beekman GM, Lard LR, de Sonnaville PBJ, Grillet BAM, Huizinga TWJ, Allaart CF.

Ann Rheum Dis. 2018 Jan;77(1):111-118. doi: 10.1136/annrheumdis-2017-211375. Epub 2017 Sep 28.

PMID:
28970207
2.

Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.

Akdemir G, Markusse IM, Goekoop-Ruiterman YP, Steup-Beekman GM, Grillet BA, Kerstens PJ, Lems WF, Huizinga TW, Allaart CF.

Clin Rheumatol. 2017 Feb;36(2):317-326. doi: 10.1007/s10067-016-3405-8. Epub 2016 Sep 28.

3.

Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost-utility analysis of the tREACH trial.

de Jong PH, Hazes JM, Buisman LR, Barendregt PJ, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE.

Rheumatology (Oxford). 2016 Dec;55(12):2138-2147. Epub 2016 Aug 30.

PMID:
27581208
4.

Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.

Kuijper TM, Luime JJ, de Jong PH, Gerards AH, van Zeben D, Tchetverikov I, de Sonnaville PB, van Krugten MV, Grillet BA, Hazes JM, Weel AE.

Ann Rheum Dis. 2016 Dec;75(12):2119-2123. doi: 10.1136/annrheumdis-2016-209272. Epub 2016 Jun 9.

PMID:
27283332
5.

Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).

Heimans L, Akdemir G, Boer KV, Goekoop-Ruiterman YP, Molenaar ET, van Groenendael JH, Peeters AJ, Steup-Beekman GM, Lard LR, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2016 Jan 21;18:23. doi: 10.1186/s13075-015-0912-y.

6.

Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis?

van der Ven M, Alves C, Luime JJ, Gerards AH, Barendregt PJ, van Zeben D, van Schaeybroeck B, de Sonnaville PB, Grillet BA, Hazes JM.

Rheumatology (Oxford). 2016 Apr;55(4):636-9. doi: 10.1093/rheumatology/kev383. Epub 2015 Nov 4.

PMID:
26538422
7.

Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?

Heimans L, Wevers-deBoer KV, Ronday HK, Collée G, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Clin Rheumatol. 2015 Jan;34(1):163-6. doi: 10.1007/s10067-014-2815-8. Epub 2014 Nov 29.

PMID:
25431327
8.

Health-related quality of life and functional ability in patients with early arthritis during remission steered treatment: results of the IMPROVED study.

Heimans L, Wevers-de Boer KV, Koudijs KK, Visser K, Goekoop-Ruiterman YP, Harbers JB, Steup-Beekman GM, Lard LR, Grillet BA, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2013 Oct 31;15(5):R173. doi: 10.1186/ar4361.

9.

A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.

Heimans L, Wevers-de Boer KV, Visser K, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C, Speyer I, de Buck MP, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2014 Jul;73(7):1356-61. doi: 10.1136/annrheumdis-2013-203243. Epub 2013 May 28.

PMID:
23716067
10.

Large-joint damage in patients with early rheumatoid arthritis and its association with treatment strategy and damage of the small joints.

Dirven L, van den Broek M, Kroon HM, Grillet BA, Han KH, Kerstens PJ, Huizinga TW, Lems WF, Allaart CF.

Rheumatology (Oxford). 2012 Dec;51(12):2262-8. doi: 10.1093/rheumatology/kes228. Epub 2012 Sep 1.

PMID:
22942403
11.

Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial.

de Jong PH, Hazes JM, Barendregt PJ, Huisman M, van Zeben D, van der Lubbe PA, Gerards AH, de Jager MH, de Sonnaville PB, Grillet BA, Luime JJ, Weel AE.

Ann Rheum Dis. 2013 Jan;72(1):72-8. doi: 10.1136/annrheumdis-2011-201162. Epub 2012 Jun 7.

PMID:
22679301
12.

Remission induction therapy with methotrexate and prednisone in patients with early rheumatoid and undifferentiated arthritis (the IMPROVED study).

Wevers-de Boer K, Visser K, Heimans L, Ronday HK, Molenaar E, Groenendael JH, Peeters AJ, Westedt ML, Collée G, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2012 Sep;71(9):1472-7. doi: 10.1136/annrheumdis-2011-200736. Epub 2012 Mar 8.

PMID:
22402145
13.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jun;68(6):914-21. doi: 10.1136/ard.2008.092254. Epub 2008 Jul 28.

PMID:
18662933
14.

Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial).

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, Kerstens PJ, Grillet BA, de Jager MH, Han KH, Speyer I, van der Lubbe PA, Seys PE, Breedveld FC, Dijkmans BA.

Ann Rheum Dis. 2007 Sep;66(9):1227-32. Epub 2007 Apr 3.

Supplemental Content

Loading ...
Support Center